whitepaper
Whitepaper: Accelerating Gαq GPCR Drug Discovery with recognized and reliable tool
Cisbio Bioassays has developed a GPCR platform based on the company’s HTRF® technology to measure second messenger accumulation...
List view / Grid view
Hit-to-Lead
news
Using PD-L1 for immunotherapy?
21 September 2016 | By Abcam
PD-L1 [28-8] (ab205921) is an ideal tool to quantify PD-L1 expression in patients for PD-1 based therapies....
article
Hit-To-Lead In-Depth Focus 2016
20 September 2016 | By Drug Target Review
In this Hit-To-Lead In-Depth Focus: Hit-to-lead in drug discovery; Zebrafish early-life stages as neurological screening and detection tools...
news
Attendee list released for the Orphan Drugs & Rare Diseases 2016
13 September 2016 | By SMi
SMi Reports (13.09. 2016, London, UK): Alexion, BioMarin, Chiesi, MHRA, NICE to meet in London in October to discuss updates in the orphan drug landscape...
article
Zebrafish early-life stages as neurological screening and detection tools
Unforeseen efficacy and safety-related issues with drugs continue to be a major cause of their attrition, despite significant efforts that are expended to eliminate them prior to initiating clinical trials...
article
Hit-to-lead in drug discovery
Starting in the 1970s, the drug discovery research process changed dramatically. Our understanding of biological targets and pathways grew and the largely empirical and target agnostic in vivo pharmacology approach was replaced with target-centric methods...
whitepaper
App note: HTRF technology essentials to boost your research
In this application note, learn how to reduce time and sample consumption while achieving highly reproducible results from your assays with HTRF technology...
news
Charles River Laboratories announces partnership with the Milner Therapeutics Institute and Consortium
10 August 2016 | By Charles River Laboratories
Charles River Laboratories announced that it has entered into a strategic partnership with the Milner Therapeutics Institute and Consortium...
product
Bio-Rad CFX96 Touch™ Real-Time PCR Detection System
4 August 2016 | By Bio-Rad Laboratories
The CFX96™ Optical Reaction Module converts the C1000 Touch™ Thermal Cycler chassis into the powerful and precise CFX96 Touch Real-Time PCR Detection System...
news
Targeting Cancer with 5 key spotlight sessions on the latest therapy breakthroughs
21 July 2016 | By SMi Group
SMi's 5th annual Cancer Vaccines event will showcase 5 key spotlight sessions on the latest advances in vaccine development and cancer therapy breakthroughs when it returns to Central London this autumn...
news
A*STAR and MSD team up to advance peptide therapeutics
19 July 2016 | By Niamh Louise Marriott
A*STAR and MSD have formed a two year collaboration aimed at improving cellular delivery of macrocyclic peptides...
news
Human Cancer Models Initiative could transform research
11 July 2016 | By Victoria White, Digital Content Producer
An international project to develop a large, globally accessible, bank of new cancer models for the research community launches today...
news
Scientists discover basal cell carcinoma cell of origin
8 July 2016 | By Victoria White, Digital Content Producer
Scientists have identified the 'cell of origin' in basal cell carcinoma and followed the chain of events that lead to the growth of these invasive tumours...
news
Scientists use a “big data” approach to precision medicine
7 July 2016 | By Victoria White, Digital Content Producer
Researchers have compared genetic mutations in tumours to those in cancer cell lines and then tested the cell lines' responses to therapeutic compounds...
news
NEAT1 identified as potential therapeutic target in the fight against cancer
4 July 2016 | By Victoria White, Digital Content Producer
Scientists have shown that NEAT1, a non-coding RNA, plays an important role in the survival of highly dividing cells - and in particular of cancer cells...
